In China, prostate cancer (PC) has become one of the malignant tumors with the fastest rising morbidity and mortality in recent years due to the gradual aging of population structure, westernization of living and eating habits, and the application and promotion of prostate-specific antigen (PSA) screening [17]. The gene discussed is KLK3; the disease is pachyonychia congenita.